The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma
Through elucidating the genetic mechanisms of drug sensitivity, precision medicine aims to improve patient selection and response to therapy. Exceptional responders are patients that exhibit exquisite and durable responses to targeted therapy, providing a rare opportunity to identify the molecular b...
Main Authors: | Amanda Pilling, Christopher Wee, Eliezer Bar-Meir, Gregory Dyson, Ok Hwang, Nilesh Gupta, Dhananjay Chitale, Clara Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2021-08-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/516277 |
Similar Items
-
Radiation-Induced Esophagitis Exacerbated by Everolimus
by: Yuji Miura, et al.
Published: (2013-06-01) -
Metastatic epithelioid angiomyolipoma treated with everolimus in a patient receiving hemodialysis: A case report
by: Manabu Takai, et al.
Published: (2019-09-01) -
Kaposi's Varicelliform-Like Eruption in a Patient Treated with Everolimus for Metastatic Renal Cell Carcinoma: Report of a Rare Case
by: Soojung Hong, et al.
Published: (2014-05-01) -
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
by: Concetta Sciammarella, et al.
Published: (2020-07-01) -
Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01)